MEDVi logo

MEDVi Review

7.1
★★★★☆3.6/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10

Best for: switching between compounded and brand-name GLP-1 through one provider

MEDVi scores below our bar on medical oversight. Read the score breakdown before signing up.

Offer50%Off 1st mo

MEDVi discount & current deal

Semaglutide injection$99/mo was$199

First month, then $199/mo

Semaglutide

$99/mo · first month

then $199/mo ongoing

Price checked on MEDVi’s site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not stated

Coaching

Included

Get the $99/mo deal →

No insurance neededVetted by our editors

PartnerMEDVi is a partner: we may earn a commission if you sign up through our links. It doesn't affect the score. How we make money

MEDVi is a telehealth weight-loss platform offering compounded GLP-1 injections and tablets (semaglutide) as well as brand-name Wegovy and Zepbound through licensed US pharmacies. Medical treatment is delivered by OpenLoop Health clinicians and CareGLP Affiliated P.C.s.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedBrandOral OptionSemaglutideTirzepatideWegovyZepbound

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

What is MEDVi?

MEDVi is an online weight-loss program where licensed clinicians from the OpenLoop Health network can prescribe GLP-1 medication after an online visit. It leads with compounded semaglutide as a weekly injection or a daily dissolvable tablet, and it also offers brand-name Wegovy and Zepbound through a separate membership. It suits people who want to start quickly with a cash-pay plan and have the option to move to a brand-name drug later.

MEDVi logo
3.6 / 5
Our editorial rating
Visit MEDVi →

from $199/mo (after intro offer) · no insurance needed

MEDVi at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide, Wegovy, Zepbound
Starting price
$199/mo (after intro offer) ($99 first month; 'Refills are locked in at $199'; the first month is $99 during MEDVi's 'FALL Sale'.)
What's included
Medication · Consult · Shipping · Coaching
Availability
48 states
FDA status
1 FDA warning letter on record; see below

How we scored MEDVi

Each dimension is scored algorithmically from MEDVi’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.5/10

At $199/mo (after intro offer), MEDVi runs about 11% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $99.

Effectiveness25%

8.2/10

MEDVi offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

7.1/10

Online intake and platform experience (consult included in the price); 7 platform features disclosed.

Trust & Safety15%

5.5/10

Core details confirmed by our editors; an FDA warning letter is on file (see flag above); discloses which pharmacy makes its medication.

Accessibility10%

8.0/10

MEDVi is available in 48 states: all but Mississippi, North Dakota.

Support10%

6.9/10

Coaching/dietitian access included.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this MEDVi review

Last checked November 2026
  • Confirmed current pricing across 2 dose/plan tiers and 2 separate fees
  • Confirmed availability in 48 states
  • Confirmed what the monthly price does and doesn't include
  • Verified the compounding pharmacy partner
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$199–$249/mo across 2 dose/plan tiers, plus 2 $99/mo fees that exclude the medication (checked November 2026)
FDA warning-letter register
An active letter is on file for this provider; see below
Compounding pharmacy partners
Triad Rx, RedRock Pharmacy, Beaker Pharmacy & Compounding

What to expect when you sign up with MEDVi

We walked MEDVi’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Medical intake questionnaire: you report your health history, goals, and current weight online.
  2. 2Checkout: you select a plan and pay before the eligibility consult (MedVi's clinician review happens after checkout).
  3. 3Telehealth consultation: an OpenLoop Health licensed clinician reviews your intake and medical history and decides whether a compounded GLP-1 is appropriate.
  4. 4If approved, the prescription ships from the pharmacy to your door; you re-report weight every 3-4 weeks for ongoing care.
Price shown before you start
  • Pricing is shown up front (compounded injections $99 for the first month, then $199) before you fill out intake. It's a flat monthly cash price rather than a dose-by-dose breakdown.
  • You pay at checkout before the clinician confirms you qualify. MedVi's site says you're refunded if you're found ineligible, but the charge comes first.
  • It's async telehealth (questionnaire + clinician review), so no baseline labs or live video visit are required. That makes it faster to start than lab-gated providers, with a lighter clinical touch.
  • Cash-pay only; MedVi notes your insurance may reimburse you for branded options. The plan bundles a personalized plan, 1:1 guidance, a metabolic report, and the medication.
  • Care is delivered by OpenLoop Health clinicians, a named, established telehealth clinician network, and they retain the prescribing decision.

GLP-1 medications MEDVi offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Compounded GLP-1 Injection (weekly)Compounded
$199$99/mo
Save 50% right now
semaglutide

'Refills are locked in at $199'; the first month is $99 during MEDVi's 'FALL Sale'.

Compounded GLP-1 Tablets (daily dissolvable)Compounded
$249/mo
semaglutide

Flat price: 'Starting at $249'. No intro discount is shown.

Wegovy Pill / Wegovy Injection (membership fee only; medication cost not published)Fee — not a medication price
$99/mo

$99 membership plus the medication cost, which MEDVi does not publish (it varies, and insurance may reimburse). 'Availability is subject to change.'

Zepbound Injection (membership fee only; medication cost not published)Fee — not a medication price
$99/mo

$99 membership plus the medication cost, which MEDVi does not publish.

Ready to get started?

Plans and promotions change often, so check MEDVi's current pricing and active discounts before you decide.

See MEDVi pricing →

MEDVi compounding-pharmacy partners

Each partner below is a 503A or 503B pharmacy that MEDVi routes prescriptions through.

Compare every compounding pharmacy we’ve reviewed →

What we like

  • Both compounded and brand-name (Wegovy, Zepbound) GLP-1 options in one platform
  • Oral tablet and injectable formats
  • Named US pharmacy partners (Triad Rx, RedRock Pharmacy, Beaker Pharmacy & Compounding)
  • Clinical oversight through OpenLoop Health provider network and CareGLP Affiliated P.C.s
  • Direct-to-home shipping with 24/7 support

Watch-outs

  • Refill price for the compounded GLP-1 injection ($199) is double the $99 first-month offer
  • Not available in Mississippi or North Dakota (telehealth regulation constraints)
  • Alabama and California patients can only receive injectable formats, not tablets, per state law
  • Kansas, Indiana, New Mexico, Oklahoma, and West Virginia require a synchronous provider visit before prescribing
  • You pay at checkout before a clinician confirms you qualify, and monthly plans aren't refunded once the month has started

MEDVi at a glance: one platform, both compounded and brand-name GLP-1

Most GLP-1 telehealth services pick a lane: they either sell cheaper compounded medication or they route you toward brand-name Wegovy and Zepbound. MEDVi is built around the opposite idea. It lets you start on lower-cost compounded semaglutide and, if you'd rather move to an FDA-approved branded drug, switch to Wegovy or Zepbound (tirzepatide) without leaving the platform or rebuilding your care from scratch. If you don't know yet whether you want to stay compounded for the savings or graduate to a name-brand pen, that flexibility is the single best reason to consider MEDVi.

The flip side is that MEDVi says little about its pharmacies' accreditation, and the price you see in month one is not the price you keep paying. Both points matter, and we cover them below.

How MEDVi's pricing works

MEDVi runs two different pricing structures depending on whether you choose compounded or brand-name medication, and confusing the two is the easiest way to be surprised by your bill.

On the compounded side, the medication is bundled into one program fee. Your monthly cost covers the physician review, your personalized plan, 1:1 guidance, a metabolic report, and the prescription shipped to your door. There's no separate charge for the drug itself. The introductory rate of $99 for the first month of compounded GLP-1 injection is the headline you'll see, but refills are $199 a month after that, so the first-month figure is a teaser, not your ongoing cost. Compounded tablets sit at their own higher tier, starting at $249 a month. For context, the category median is $179, and the post-promo refill is what you should budget around.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

Brand-name Wegovy and Zepbound work differently: those run on a membership-plus-medication model, where you pay a monthly membership and then the cost of the branded drug on top. That can be the right choice if you want the exact FDA-approved product, but it is a meaningfully different (and usually pricier) commitment than the all-in compounded program.

What you're paying for

  • Compounded program: one bundled fee that includes the medication, clinician review, shipping, and coaching
  • Brand program: an approximately ninety-nine-dollar membership fee plus the separate cost of Wegovy or Zepbound
  • Included with both: free shipping, no insurance required, and free dietitian visits and care coaching

The medications and who dispenses them

MEDVi offers compounded semaglutide as both an injection and an oral tablet, plus brand-name Wegovy (pill or injection) and Zepbound. The oral tablet option is useful for needle-averse patients (not every provider offers a swallowable semaglutide), though Alabama and California patients are limited to injectables only because of state law.

Where MEDVi earns some credit is transparency about its supply chain. Rather than hiding behind a vague 'licensed pharmacy partner,' the company names the three compounding pharmacies it works with: Triad Rx in Daphne, Alabama; RedRock Pharmacy in St. George, Utah; and Beaker Pharmacy & Compounding in McKinney, Texas. The medical side is handled by the OpenLoop Health clinician network and CareGLP Affiliated P.C.s. Naming locatable US pharmacies and a known telehealth provider group is more disclosure than many compounded-GLP-1 sites offer.

The differentiator: switchability without starting over

The reason to choose MEDVi over a cheaper compounded-only service is optionality. You can begin on compounded semaglutide to control costs, then move to brand-name Zepbound if your insurance situation changes, if supply tightens, or if you simply decide you want the FDA-approved product. It all stays under one account, one clinical record, and one coaching relationship. For people who are still deciding what they want long-term, that removes the friction of switching providers mid-journey, which is a specific, practical advantage.

Where MEDVi falls short

Two things should give you pause. First, the accreditation gap: MEDVi displays a LegitScript seal, but it doesn't publish PCAB or other accreditation for its compounding pharmacies. That doesn't mean they are unaccredited, but for a compounded-medication service it is a fair reason to ask questions before you commit. Second, the price step-up: the attractive first-month compounded injection rate rises from $99 to $199 at refill, so anyone shopping purely on that opening number is likely to feel the increase by month two.

  • No published PCAB accreditation for its pharmacies, so confirm accreditation directly before ordering
  • Refill pricing jumps well above the first-month compounded injection offer
  • Not available in [Mississippi](/states/mississippi) or [North Dakota](/states/north-dakota) due to telehealth rules
  • Alabama and California are injectable-only, no tablets
  • Kansas, Indiana, New Mexico, Oklahoma, and West Virginia require a live provider visit before prescribing

Who should choose MEDVi, and who should skip it

Choose MEDVi if you value the freedom to move between compounded and brand-name GLP-1 within one platform, if you want an oral tablet option, and if a bundled program fee with included coaching and free shipping fits how you like to pay. It covers 48 states, so most US patients can access it.

Skip it if you want a service that leads with its accreditations (one that does is Ivologist, which holds a LegitScript certification and serves all 50 states), or if you're optimizing purely for the lowest long-term compounded price (the refill rate isn't the cheapest around). Skip it too if you live in a state with the synchronous-visit requirement and want a fully asynchronous experience. Compare its ongoing cost against the $179 category median using our scoring methodology before you lock in.

Bottom line

MEDVi is a solid pick for the specific patient who wants a single home for both compounded and brand-name GLP-1 and the ability to switch between them. The pharmacy and clinician disclosure is better than average, and the compounded program's all-in pricing is convenient. Go in with eyes open on two fronts: the refill price is the number that matters, not the first-month teaser, and the lack of published pharmacy accreditation deserves a direct question before you hand over a card. Treat it as a flexible, mid-priced option (not the cheapest, and not the most credential-forward) and it can be a smart fit.

The Bottom Line

MEDVi scores below our bar on medical oversight. Read the score breakdown before signing up.

Score: 7.1/10Best for: switching between compounded and brand-name GLP-1 through one providerFrom: $199/mo (after intro offer)

Ready to start with MEDVi?

From $199/mo (after intro offer). See current pricing and start your free consultation.

Alternatives to MEDVi

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →

Head-to-head

Compare MEDVi vs…

MEDVi scores7.1/10

Side-by-side pricing, medications and scores. Pick a matchup.

All 45 MEDVi comparisons

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

MEDVi delivers clinical care through OpenLoop Health and CareGLP Affiliated P.C.s, established telehealth infrastructure providers used across multiple GLP-1 platforms. The company reports over 500,000 patients served and publicly names three U.S. compounding pharmacy partners, a level of transparency that is uncommon in this market. MEDVi also displays a LegitScript seal on its site. Overall, the licensed provider network, named dispensing pharmacies, and established patient volume suggest a provider operating seriously in the compounded GLP-1 space.
MEDVi is a telehealth weight loss platform that offers both compounded and brand-name GLP-1 medications through a single program. On the compounded side it provides weekly injectable semaglutide and daily dissolvable semaglutide tablets. For patients who qualify, it also offers brand-name Wegovy and Zepbound, giving patients the option to start with a compounded medication and transition to a brand-name product as their plan evolves. Clinical care is provided by licensed professionals through the OpenLoop Health network and CareGLP Affiliated P.C.s. MEDVi is currently available in 48 states. Mississippi and North Dakota are excluded due to telehealth regulation constraints.
MEDVi's main page lists brand-name Zepbound for a $99 monthly membership plus the medication, which MEDVi doesn't price. Some MEDVi landing pages also advertise compounded tirzepatide injections at $166 a month, so confirm the price at checkout.
Yes. MEDVi sells compounded semaglutide as a dissolvable tablet you take once a day, starting at $249 a month, and brand-name Wegovy pills for a $99 monthly membership plus the medication cost. Tablets aren't available in Alabama or California, where only injections are offered.
MEDVi uses an introductory price for compounded GLP-1 injections: the first month is $99 during its current sale, and refills are locked in at $199 per month. Compounded semaglutide tablets start at $249 per month. Brand-name Wegovy and Zepbound require a $99 monthly membership fee plus the medication cost, which MEDVi doesn't publish. Factor the jump from $99 to $199 at month two into your budget before enrolling.
MEDVi's key advantages are breadth and named pharmacy partners. Compounded injectables, oral tablets, and brand-name GLP-1s (Wegovy, Zepbound) all come through one provider, and MEDVi names the three pharmacies it works with. Free dietitian visits, care coaching, and free shipping are included, comparing favorably to platforms that bill for these separately. On the downside, the refill price for compounded injections ($199) is double the $99 first-month offer, and the platform is unavailable in Mississippi and North Dakota. Several states including Kansas, Indiana, New Mexico, Oklahoma, and West Virginia also require a synchronous provider visit before a prescription can be issued.
Yes. In addition to compounded semaglutide, MEDVi offers brand-name Wegovy (pill or injection) and Zepbound for patients who qualify. Brand-name access requires a $99 monthly membership fee on top of the medication cost, which varies by insurance coverage. Brand-name GLP-1s are FDA-approved finished drug products, unlike MEDVi's compounded options, which are prepared by licensed compounding pharmacies and are not individually FDA-approved. Patients who prefer an FDA-approved product or have insurance that covers brand-name GLP-1s may find the brand pathway through MEDVi a suitable option to discuss with their provider.
The main red flag is an FDA warning letter on file, which this review flags. Read it before starting. We also note: Refill price for the compounded GLP-1 injection ($199) is double the $99 first-month offer; Not available in Mississippi or North Dakota (telehealth regulation constraints); Alabama and California patients can only receive injectable formats, not tablets, per state law.
No. Every MEDVi prescription is cash-pay, and its affiliated providers are out of network with all insurance plans. If you choose a brand-name medication, MEDVi says your insurance may reimburse you for it, but you pay MEDVi directly either way.
Yes. You pay for your first month at checkout, and a clinician reviews your case after that to decide whether you qualify. If the provider disqualifies you for a medical reason, MEDVi gives you a full refund.
MEDVi doesn't make or dispense medication itself. Its partner pharmacies are Triad Rx in Daphne, Alabama; RedRock Pharmacy in St. George, Utah; and Beaker Pharmacy & Compounding in McKinney, Texas.
No public promo code is listed on MEDVi's website. Instead, it advertises a lower introductory price for your first month of compounded semaglutide, and refills move to the regular monthly price after that.
MEDVi offers support around the clock. You can reach the team by email, by phone, or through the chat feature in your patient portal, which is also where you can request a cancellation. To avoid your next charge, cancel at least 72 hours before your billing date.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Regulatory notice

MEDVi received an FDA warning letter dated February 20, 2026

The letter concerns false & misleading claims/misbranded. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.

Read the full letter →

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this MEDVi review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See MEDVi's current pricing

Plans from $199/mo (after intro offer). Start your free consultation to check eligibility and today's price.